469 related articles for article (PubMed ID: 32338209)
1. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products.
Bilski J; Wojcik D; Danielak A; Mazur-Bialy A; Magierowski M; Tønnesen K; Brzozowski B; Surmiak M; Magierowska K; Pajdo R; Ptak-Belowska A; Brzozowski T
Curr Pharm Des; 2020; 26(25):2936-2950. PubMed ID: 32338209
[TBL] [Abstract][Full Text] [Related]
2. The Combination of Intestinal Alkaline Phosphatase Treatment with Moderate Physical Activity Alleviates the Severity of Experimental Colitis in Obese Mice via Modulation of Gut Microbiota, Attenuation of Proinflammatory Cytokines, Oxidative Stress Biomarkers and DNA Oxidative Damage in Colonic Mucosa.
Wojcik-Grzybek D; Hubalewska-Mazgaj M; Surmiak M; Sliwowski Z; Dobrut A; Mlodzinska A; Wojcik A; Kwiecien S; Magierowski M; Mazur-Bialy A; Bilski J; Brzozowski T
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328382
[TBL] [Abstract][Full Text] [Related]
3. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence.
Bilski J; Mazur-Bialy A; Brzozowski B; Magierowski M; Zahradnik-Bilska J; Wójcik D; Magierowska K; Kwiecien S; Mach T; Brzozowski T
Pharmacol Rep; 2016 Aug; 68(4):827-36. PubMed ID: 27255494
[TBL] [Abstract][Full Text] [Related]
4. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.
Bilski J; Mazur-Bialy A; Wojcik D; Surmiak M; Magierowski M; Sliwowski Z; Pajdo R; Kwiecien S; Danielak A; Ptak-Belowska A; Brzozowski T
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779136
[TBL] [Abstract][Full Text] [Related]
5. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
6. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
7. Role of alkaline phosphatase in colitis in man and rats.
Tuin A; Poelstra K; de Jager-Krikken A; Bok L; Raaben W; Velders MP; Dijkstra G
Gut; 2009 Mar; 58(3):379-87. PubMed ID: 18852260
[TBL] [Abstract][Full Text] [Related]
8. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.
Guo BJ; Bian ZX; Qiu HC; Wang YT; Wang Y
Ann N Y Acad Sci; 2017 Aug; 1401(1):37-48. PubMed ID: 28891095
[TBL] [Abstract][Full Text] [Related]
9. The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract.
Bilski J; Mazur-Bialy A; Wojcik D; Zahradnik-Bilska J; Brzozowski B; Magierowski M; Mach T; Magierowska K; Brzozowski T
Mediators Inflamm; 2017; 2017():9074601. PubMed ID: 28316376
[TBL] [Abstract][Full Text] [Related]
10. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
Yao Y; Liu Y; Xu Q; Mao L
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257292
[TBL] [Abstract][Full Text] [Related]
11. Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: A review.
Koutouratsas T; Philippou A; Kolios G; Koutsilieris M; Gazouli M
World J Gastroenterol; 2021 Aug; 27(30):5037-5046. PubMed ID: 34497433
[TBL] [Abstract][Full Text] [Related]
12. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases.
Hyun CK
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502047
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease.
Perera AP; Kunde D; Eri R
Curr Pharm Des; 2017; 23(16):2321-2327. PubMed ID: 28155620
[TBL] [Abstract][Full Text] [Related]
14. Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity.
Estaki M; DeCoffe D; Gibson DL
World J Gastroenterol; 2014 Nov; 20(42):15650-6. PubMed ID: 25400448
[TBL] [Abstract][Full Text] [Related]
15. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
Terc J; Hansen A; Alston L; Hirota SA
Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
[TBL] [Abstract][Full Text] [Related]
16. Practical Considerations and the Intestinal Microbiome in Disease: Antibiotics for IBD Therapy.
Fedorak RN; Ismond KP
Dig Dis; 2016; 34(1-2):112-21. PubMed ID: 26982586
[TBL] [Abstract][Full Text] [Related]
17. Point-of-Care Monitoring of Colitis Using Intestinal Alkaline Phosphatase in Inflammatory Bowel Disease.
Sheng X; Liu D; Gamage SK; Luo Y; Viennois E; Merlin D; Iyer SS
ACS Sens; 2021 Mar; 6(3):698-702. PubMed ID: 33635063
[TBL] [Abstract][Full Text] [Related]
18. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
[TBL] [Abstract][Full Text] [Related]
19. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis.
Eichele DD; Kharbanda KK
World J Gastroenterol; 2017 Sep; 23(33):6016-6029. PubMed ID: 28970718
[TBL] [Abstract][Full Text] [Related]
20. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
